D I Laboratories Ltd - pharma in Kolkata, West Bengal, India. Directors, charges & compliance details.
CIN U24239WB1986PLC041034 Incorporated 31 July 1986 ROC Kolkata HQ Kolkata, West Bengal, India
Struck Off Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹17,240
▼ 97% YoY
Net profit · FY 2024
₹5,180
Net margin 30%
EBITDA · FY 2024
₹5,180
EBITDA margin 30%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Satisfied charges
₹28 Lakh
No open charges
Company age
40 yrs
Est. 1986
Employees · EPFO
28
Provident fund records

About D I Laboratories Ltd

Data last updated:

D I Laboratories Ltd was a public limited company based in Kolkata, West Bengal, India, operated as a subsidiary of Development Consultants Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 1986.

The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1986PLC041034. Its GSTIN is 19AABCD2649G1ZO (West Bengal). The company held 3 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹8 Lakh. It was led by directors including Sandip Kumar Ghosh and Swarup Chakraborty.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 24 Park Street, Kolkata, West Bengal, India – 700016.

As per the financials filed for FY 2024, the company reported a revenue of ₹17,240, a decline of 97% compared to the previous year. For the same year it recorded a net profit of ₹5,180 (net margin 30%) and EBITDA of ₹5,180 (EBITDA margin 30%). Revenue has declined at a compounded annual rate (CAGR) of 86% over three years.

The company had about 28 employees on its provident fund (EPFO) records before it was struck off.

As per MCA filings, the company had satisfied charges of ₹28 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.

Company details

CIN U24239WB1986PLC041034
Registration Number 041034
Incorporation Date 31 July 1986
ROC Kolkata
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Development Consultants Private Limited
Compliance Status Active Compliant

CIN history

D I Laboratories has one previous CIN (Corporate Identification Number): U24239WB1986PTC041034. The current CIN is U24239WB1986PLC041034, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239WB1986PLC041034Current
U24239WB1986PTC041034Previous

Contact details

D I Laboratories Ltd's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.

  • Email
  • Registered Address
    24 Park Street, Kolkata, West Bengal, India – 700016
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of D I Laboratories Ltd, buy the company report.

Comprehensive company report
D I Laboratories Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of D I Laboratories Ltd

FY 2024 filings available

D I Laboratories Ltd reported revenue of ₹17,240 (down 97% YoY) for FY 2024.

Revenue · FY 2024
₹17,240 ▼ 97%
Net profit · FY 2024
₹5,180 margin 30%
EBITDA · FY 2024
₹5,180 margin 30%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 97%
3 years · compounded
▼ 86%
EBITDA CAGR growth
1 year
▼ 99%
3 years · compounded
▼ 91%
5 years · compounded
▲ 15%

Revenue has declined at a compounded annual rate (CAGR) of 86% over three years, including a 97% fall in the latest year. EBITDA fell 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5,180
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5,180
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin30%
Net Profit Margin30%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of D I Laboratories Ltd, buy the company report.

Board of directors of D I Laboratories Ltd

D I Laboratories has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sandip Kumar GhoshDirector10 Feb 198838 Years 8 MonthsAs last reported
Swarup ChakrabortyDirector25 Nov 20223 Years 11 MonthsAs last reported
Biman SahaDirector25 Nov 200223 Years 11 MonthsAs last reported

Peer comparison

D I Laboratories Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
D. M. Medicos Private Limited₹18,926 (FY 2025)11.0%Delhi, India
Paramount Pharma Care Private Limited₹18,700 (FY 2023)13.0%Siliguri, West Bengal, India
Symlux Pharmaceuticals Private Limited₹18,370 (FY 2023)-77.0%Thane, Maharashtra, India
Bonafide Nutrition Private Limited₹18,132 (FY 2024)-98.0%Yamuna Nagar, Haryana, India
V3 Biotechnologies Private Limited₹17,500 (FY 2025)8.0%Kolkata, West Bengal, India
D I Laboratories Ltdthis company₹17,240 (FY 2024)₹5,18030%-97.0%28Kolkata, West Bengal, India
DMK Ventures Private Limited₹17,000 (FY 2025)-70.0%Ahmedabad, Gujarat, India
GSR International Private Limited₹16,855 (FY 2017)77.0%New Delhi, Delhi, India
Monozyme India Limited₹16,600 (FY 2025)14.0%Secunderabad, Telangana, India
Sanjhi Foodco Industries Private Limited₹16,437 (FY 2025)0.0%Nagpur, Maharashtra, India
Shakti Bio Science Limited₹16,378 (FY 2025)-99.0%Vapi, Gujarat, India

To see the full peer comparison of D I Laboratories Ltd, buy the company report.

Shareholding

The shareholding of D I Laboratories Ltd is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of D I Laboratories Ltd, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹28 Lakh
Breakdown by lending institutions
Uco Bank₹0.28 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Dec 198790255619Uco Bank₹28 LakhSatisfied

To see the full charge records of D I Laboratories Ltd, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for D I Laboratories Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

D I Laboratories Ltd has a workforce of 28 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.

Employee count
28
Active EPFO establishments
1
Employee growth
-20%

GST

D I Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
19AABCD2649G1ZOWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of D I Laboratories Ltd, buy the company report.

Recent activity

D I Laboratories Ltd has 9 board changes on record since 1988: 3 appointments and 6 cessations. The latest: Swarup Chakraborty ceased to be Additional Director on 29 Aug 2023.

AGM
D I Laboratories Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
D I Laboratories Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Ceased
Swarup Chakraborty ceased to be Additional Director.
Appointed
Swarup Chakraborty was appointed as Director.
Ceased
Aniruddha Sarkar ceased to be Additional Director.
Ceased
Sandip Kumar Ghosh ceased to be Director.
Charges
A charge registered on 14 Dec 1987 via Charge ID 90255619 with Uco Bank was fully satisfied on 11 Jul 2018.
Ceased
Shanta Ghosh ceased to be Director.
Ceased
Arun Kumar Guha ceased to be Director.
Ceased
Sadhan Chandra Dutt ceased to be Director.
Charges
A charge with Uco Bank of Rs. 28.00 Lakh registered on 14 Dec 1987 with Charge ID 90255619 was modified on 25 Jun 2004.
Appointed
Biman Saha was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

D I Laboratories has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

D I Laboratories was a public limited company based in Kolkata, West Bengal, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 31 July 1986 and is registered under CIN U24239WB1986PLC041034. The company has been struck off by the Registrar of Companies and is no longer operational.

D I Laboratories had 3 directors:

The CIN (Corporate Identification Number) of D I Laboratories is U24239WB1986PLC041034. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of D I Laboratories is at 24 Park Street, Kolkata, West Bengal, India – 700016.

D I Laboratories was incorporated on 31 July 1986. It is registered with the Registrar of Companies, Kolkata.

The latest financial statements of D I Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of D I Laboratories is 19AABCD2649G1ZO, registered in West Bengal. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

D I Laboratories operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.

The peers of D I Laboratories by revenue are D. M. Medicos Private Limited, Paramount Pharma Care Private Limited, Symlux Pharmaceuticals Private Limited, Bonafide Nutrition Private Limited, V3 Biotechnologies Private Limited and 5 more, all in the Pharma industry (Formulations).

D I Laboratories has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the high courts.